Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors
Edmondson, S.D., Wei, L., Xu, J., Shang, J., Xu, S., Pang, J., Chaudhary, A., Dean, D.C., He, H., Leiting, B., Lyons, K.A., Patel, R.A., Patel, S.B., Scapin, G., Wu, J.K., Beconi, M.G., Thornberry, N.A., Weber, A.E.(2008) Bioorg Med Chem Lett 18: 2409-2413
- PubMed: 18331795 
- DOI: https://doi.org/10.1016/j.bmcl.2008.02.050
- Primary Citation of Related Structures:  
3C43, 3C45 - PubMed Abstract: 
The synthesis, selectivity, rat pharmacokinetic profile, and drug metabolism profiles of a series of potent fluoroolefin-derived DPP-4 inhibitors (4) are reported. A radiolabeled fluoroolefin 33 was shown to possess a high propensity to form reactive metabolites, thus revealing a potential liability for this class of DPP-4 inhibitors.
Organizational Affiliation: 
Department of Medicinal Chemistry, Merck & Co. Inc., PO Box 2000, Rahway, NJ 07065, USA. scott_edmondson@merck.com